FDA Approves Vabysmo, The First Bispecific Antibody For The Eye!
The US Food and Drug Administration has approved Vabysmo (faricimab-svoa), for the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME).
The US Food and Drug Administration has approved Vabysmo (faricimab-svoa), for the treatment of wet age-related macular degeneration (AMD) and diabetic macular oedema (DME).
Many patients with diabetes are painless when their blood sugar is high, and retinopathy is also silent and imperceptible. Therefore, the majority of diabetes patients should be reminded that after the diagnosis of diabetes, they must regularly screen the sugar network, and early diagnosis and treatment is the key. Early detection, early treatment and regular reexamination can avoid more than 90% of severe visual impairment.
The Bascom Palmer EyeInstitute has been ranked by U.S. News & World Report and Ophthalmology Times as the No. 1 ophthalmologist in the U.S. U.S. News & World Report has been surveying doctors nationwide and ranking institutions nationally for 27 years, and this is the 17th time the Bascom Palmer EyeInstitute has been considered the No. 1 ophthalmologist.
Eye cancer is a very dangerous disease, and as the disease develops, it will affect the patient's body more and more, so it is important for eye cancer patients to receive timely treatment.